The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction

Shen, Sherry, Solomon, Verna, Williams, Dominiq, Robson, Mark E, Norton, Larry, Traina, Tiffany A, Iyengar, Neil M (2023) The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction. In: UNSPECIFIED.

Item Type: Conference or Workshop Item (Paper)
Subjects: diseases & disorders > cancer > cancer types > breast cancer
diseases & disorders > cancer > metastasis
CSHL Authors:
Communities: CSHL labs > Wigler lab
SWORD Depositor: CSHL Elements
Depositing User: CSHL Elements
Date: 2023
Date Deposited: 11 Oct 2023 15:21
Last Modified: 11 Oct 2023 15:21
Related URLs:
URI: https://repository.cshl.edu/id/eprint/41181

Actions (login required)

Administrator's edit/view item Administrator's edit/view item